Awarded contract

NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products

Details

Value
GBP 321,349,256
Duration
2 years
Topic
Pharmaceutical products
Published
28 November 2025

Tender description

NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux Products – CM/PHR/25/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. ## Contract award Title: NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins ## Contract award

Timeline

  1. Completed: Award published28 November 2025
    Current notice
  2. Completed: Award date28 November 2025
  3. Next: Contract expiry date29 February 2028in 18 months

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33600000 · Pharmaceutical products

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

6 similar open tenders

See more open tenders related to NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products.

Explore all open tenders

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.